Novo releases GLP-1 pill, bitcoin price rises, Qualcomm’s chips
January 5, 2026
Market Domination host Josh Lipton outlines three of the top stories investors are watching on Monday: Novo Nordisk’s (NVO) launching its GLP-1 pill, bitcoin’s (BTC-USD) bullish start to 2026, and Qualcomm’s (QCOM) CES announcements.
To watch more expert insights and analysis on the latest market action, check out more Market Domination.
00:03 Speaker A
All right, time for some of today’s trending tickers. We’re going to start off here on Novo Nordis.
00:09 Speaker A
Those shares moving higher after launching the first ever GLP-1 pill for obesity in the US, marking a major shift in the weight loss drug market.
00:23 Speaker A
The oral version of Vagovi is rolling out nationwide at more than 70,000 pharmacies with cash prices starting at $149 a month.
00:32 Speaker A
That’s below the list price of injectable GLP-1s.
00:37 Speaker A
Taking a look over at Bitcoin as well. Prices climbing back here above 94,000, signaling what some analysts see as a renewed bullish turn to start 2026.
00:46 Speaker A
Crypto research firm 10X says trading volumes are normalizing and institutional positioning is beginning to rebuild after a rough end to 2025.
00:57 Speaker A
And finally, let’s take a look over at Qualcomm too. Those shares gaining in today’s trade. The company unveiling new hardware at CES as it pushes deeper into the PC and AI markets.
01:06 Speaker A
Qualcomm also announcing a humanoid robotics initiative and projecting that market could reach $1 trillion by 2040.
Terms and Privacy Policy
Search
RECENT PRESS RELEASES
Related Post
